Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Electronic screening tool to triage teenagers and risk of substance misuse

  • Mortality rates increase due to extreme heat and cold

  • Diverse boards pay more dividends, take fewer risks, study finds

  • Help your infant or toddler cope with stressful events

  • Autistic brain less flexible at taking on tasks

  • Social origins of intelligence in the brain

  • Brand-specific television alcohol ads a significant predictor of brand consumption among underage youth

  • Brainwaves can predict audience reaction of television programming

  • Watching neurons fire from a front-row seat

  • Vision-correcting display makes reading glasses so yesterday

  •